Dr. Christopher E. Forsmark, MD

Dr. Forsmark practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Forsmark's NPI, 1780626044, was assigned on June 12, 2006. Dr. Forsmark graduated from The Johns Hopkins University School of Medicine in 1983. Dr. Forsmark holds Florida license ME58138.

Dr. Forsmark's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Forsmark's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Forsmark practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Forsmark's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Forsmark is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Forsmark's licenses on file in 2 states: Florida and California.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, bile duct problems, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and irritable bowel syndrome (IBS) among the conditions Dr. Forsmark treats.

CMS data shows 400 Medicare services from Dr. Forsmark across 11 procedure codes in 2024, for 326 Medicare patients. Medicare paid $33,060 for them.

CMS counts 326 Medicare patients who saw Dr. Forsmark in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Forsmark's median patient age at 72, with 54% women.

In 2024, Dr. Forsmark wrote 1,269 Medicare Part D claims for 1,059 patients. 77% of them were for generic drugs. CMS names the drug for 1,178 of them, across 12 drugs with 11 or more claims each, at $453,808 in total drug cost. In 2023, CMS named 858 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Forsmark for performance year 2024, reported through an alternative payment model (APM). Dr. Forsmark accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 93 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Forsmark, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 79 papers to Dr. Forsmark, published from 2010 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Pancreatitis, Chronic, Pancreatitis and Cholangiopancreatography, Endoscopic Retrograde. Dr. Forsmark has published most often in Pancreas. Dr. Forsmark's most frequent co-authors are Charles Melbern Wilcox, MD, Darwin L. Conwell, MD and Randall E. Brand.

Dmand AI links Dr. Forsmark to 2 clinical trials. Conditions studied include Pancreatitis and Pancreatic Diseases.

CMS Open Payments shows 118 general payments to Dr. Forsmark from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Boehringer Ingelheim Corporate Center GmbH paid the most, $60,150.

Dmand AI lists 5 awards for Dr. Forsmark, most recently America's Top Doctors in 2019.

Dr. Forsmark graduated from The Johns Hopkins University School of Medicine in 1983. Dr. Forsmark is a member of ACP and AGA.

Dr. Forsmark is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.